Tali Digital Ltd (ASX: TD1) is an ASX-listed technology services company with a market capitalisation of approximately 2.94 million Australian dollars. Shares fell 1.59 percent to 6.2 cents on the day, with just 137 shares traded at a relative volume of 0.00.

Tali Digital has developed digital cognitive assessment tools for children, particularly targeting attention assessment. The following covers the company's background and key investor considerations.

Key Stock Details

• ASX Code: TD1

• Market Cap: Approximately 2.94 M AUD.

• Price: 6.2 cents, down 1.59 percent on the day.

• Volume: 137 shares, relative volume 0.00.

• P/E Ratio: -

• EPS (diluted TTM): Negative 0.02 AUD

• EPS Growth TTM YoY: Negative 64.67 percent: worsening

• Dividend Yield: Nil

• Analyst Rating: No coverage

Key Project Highlights

• Cognitive Assessment: Tali Digital operates in the Technology Services sector.

• Share price: 6.2 cents: down 1.59 percent on the day.

• EPS trend: Negative 64.67 percent: worsening

• Coverage: No coverage

Company Background

Tali Digital has developed a digital platform for cognitive assessment and attention training in children. The company's products use gamified tasks to assess and potentially support cognitive functions, with a focus on attention which is relevant to conditions such as attention deficit hyperactivity disorder and related developmental concerns.

Digital health tools for cognitive assessment represent a growing area of healthcare technology, with increasing interest from clinicians and parents in accessible tools that can support assessment outside traditional clinical settings. Tali's approach of using engaging digital tasks could make assessment more accessible and less confronting for children than traditional clinical testing.

The worsening EPS of 64.67 percent year on year indicates the company's financial position is deteriorating significantly. For a digital health company, this could reflect increased development spending, commercial costs or declining revenue from prior periods.

Sector and Market Context

Digital health technology for children's cognitive health sits at the intersection of education technology, health technology and clinical assessment. Companies in this space must meet regulatory requirements for health-related software, demonstrate clinical validity and navigate procurement processes in healthcare and education systems.

The market for children's cognitive assessment tools includes both clinical and consumer segments, with different value propositions and sales processes for each. Building credibility in clinical settings requires validation studies and engagement with healthcare professionals.

Financial Position

The EPS deterioration of 64.67 percent is one of the more significant worsening trends in this dataset. At a market value of 2.94 million dollars and a share price of 6.2 cents, the company needs to demonstrate a clear path to improving its financial trajectory.

The trading of only 137 shares at 6.2 cents represents a total transaction value of approximately 8.50 dollars. This minimal activity means the price effectively sat unchanged from any market pressure perspective.

Investor Insights

Tali Digital has a genuine healthcare technology product addressing a real clinical need in cognitive assessment for children. However, the significant worsening in financial position is a serious concern that requires investigation into the underlying drivers.

Whether the EPS deterioration reflects a temporary investment phase or a structural decline in the business requires careful review of the financial statements and commercial performance.

Risk Considerations

Key risks include significant EPS deterioration, near-zero liquidity (137 shares traded), the challenge of commercialising health technology for children and the very small market value.

Clinical validation and regulatory compliance requirements for health technology add costs and timelines that can challenge small companies with limited capital.